1. Cell Cycle/DNA Damage Epigenetics PI3K/Akt/mTOR MAPK/ERK Pathway Stem Cell/Wnt
  2. Sirtuin HDAC Akt mTOR Ribosomal S6 Kinase (RSK) ERK
  3. SIRT6-IN-3

SIRT6-IN-3 (compound 8a) 是 SIRT6 的选择性抑制剂 (IC50 为 7.49 μM)。SIRT6-IN-3 抑制胰腺导管腺癌 (PDAC) 细胞增殖并诱导细胞凋亡 (apoptosis)。SIRT6-IN-3 通过阻止 DNA 损伤修复来增加吉西他滨 (HY-17026) 对癌细胞的敏感性。SIRT6-IN-3 用于胰腺癌研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

SIRT6-IN-3 Chemical Structure

SIRT6-IN-3 Chemical Structure

CAS No. : 3023471-40-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货
1 mg ¥2000
询问价格 & 货期
5 mg ¥5000
询问价格 & 货期
10 mg 现货 询问价格 & 货期
25 mg 现货 询问价格 & 货期
50 mg 现货 询问价格 & 货期

* Please select Quantity before adding items.

Customer Review

查看 Sirtuin 亚型特异性产品:

查看 HDAC 亚型特异性产品:

查看 Akt 亚型特异性产品:

查看 mTOR 亚型特异性产品:

查看 Ribosomal S6 Kinase (RSK) 亚型特异性产品:

查看 ERK 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

SIRT6-IN-3 (compound 8a) is a selective inhibitor of SIRT6 (IC50=7.49 μM). SIRT6-IN-3 inhibits pancreatic ductal adenocarcinoma (PDAC) cells proliferation and induces apoptosis. SIRT6-IN-3 increases the sensitivity of cancer cells to gemcitabine (HY-17026) via blocking the DNA damage repair pathway. SIRT6-IN-3 is used in pancreatic cancer research[1].

IC50 & Target

SIRT1

80.52 μM (IC50)

SIRT2

92.21 μM (IC50)

SIRT6

7.46 μM (IC50)

HDAC3

111.9 μM (IC50)

HDAC6

96.77 μM (IC50)

HDAC8

102 μM (IC50)

体外研究
(In Vitro)

SIRT6-IN-3 (25 μM,48 小时) 诱导 PDAC 细胞周期阻滞和细胞凋亡[1]
SIRT6-IN-3 (25 μM,72 小时) 通过抑制细胞信号通路来抑制胰腺癌细胞的增殖[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[1]

Cell Line: PDAC cells
Concentration: 0, 6.25, 12.5, 25 μM
Incubation Time: 48 h
Result: Increased the percentages of the G0-G1 phase and decreased cyclin D1 expression in a dose-dependent manner.

Western Blot Analysis[1]

Cell Line: PDAC cells
Concentration: 0, 6.25, 12.5, 25 μM
Incubation Time: Overnight
Result: Significantly down-regulated p-mTOR, p-P70S6K, p-AKT, and p-ERK.
Inhibited the activity of both mTORC1 and mTORC2.
Significantly up-regulated the expression of cleaved-PARP, cleaved-Caspase3, and cleaved-Caspase9.
体内研究
(In Vivo)

SIRT6-IN-3 (HY-156027;20 mg/kg,腹腔注射;两天一次,连用四周) 在肿瘤小鼠模型中有抗肿瘤作用[1]
SIRT6-IN-3 (HY-156027;20 mg/kg,腹腔注射;两天一次,连用四周) 在与吉西他滨 (比例 2 : 1 ) 联用时增强了吉西他滨的抗肿瘤作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Tumor mouse model[1]
Dosage: 20 mg/kg (in combination with 10 mg/kg gemcitabine)
Administration: Intraperitoneal injection (i.p.); Once every 2 days for 4 weeks
Result: Inhibited the tumor mass 71.3% in mice with combinations of gemcitabine.
Greatly increased the expression of apoptosis maker.
分子量

673.73

Formula

C21H30Br3ClN6S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
SIRT6-IN-3
目录号:
HY-156027
需求量: